BioXcel Therapeutics, Inc. (BTAI) Investor Alert: Robbins LLP Reminds Investors of Class Action Against BioXcel Therapeutics, Inc.

<p>SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) &#8212; Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel Therapeutics, Inc. (NASDAQ: BTAI) securities between December 15, 2021 and June 28, 2023. BioXcel is a biopharmaceutical company that claims it uses artificial intelligence [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/bioxcel-therapeutics-inc-btai-investor-alert-robbins-llp-reminds-investors-of-class-action-against-bioxcel-therapeutics-inc/">BioXcel Therapeutics, Inc. (BTAI) Investor Alert: Robbins LLP Reminds Investors of Class Action Against BioXcel Therapeutics, Inc.</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>